Enhancement of the antiparakeratotic potency of calcitriol and tacalcitol in liposomal preparations in the mouse tail test

Skin Pharmacology and Applied Skin Physiology

Volumn 14, Issue 5, 2001, Pages 291-295

  Korbel J N ^a   Sebok B ^b   Kerenyi M ^b   Mahrle, G ^a,c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF PÉCS   (Hungary)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Calcitriol; Liposomal preparation; Mouse tail test; Tacalcitol

Indexed keywords

CALCIPOTRIOL; CALCITRIOL; LIPOSOME; PETROLATUM; PHOSPHOLIPID; TACALCITOL;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ENCAPSULATION; HISTOPATHOLOGY; KERATOSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL;

EID: 0035741950     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056359     Document Type: Article

References (26)

1. 3 analogues in the treatment of psoriasis
2. The effect of tacalcitol (1,24(OH)2D3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: A placebo-controlled, double-blind study
3. 3 analogs
4. Biological effects of topical calcipotriol (MC 903) treatment in psoriatic skin
5. Occlusion enhances the efficacy of topical calcipotriol in the treatment of psoriasis vulgaris
6. Therapeutischer nutzen von tacalcitol bei der psoriasis vulgaris unter besonderer berücksichtigung der okklusiven applikation
7. Die kutane applikation von liposomen - Eine literaturübersicht unter besonderer berücksichtigung der befunde von keratinozytenkulturen, tierexperimenten sowie klinischen studien
8. Topical liposome drugs to come: What the patent literature tells us
9. Liposomes: A drug carrier system for topical treatment in dermatology
10. The effect of liposomal incorporation of topically applied hydrocortisone on its serum concentration and urinary excretion
11. Cutaneous bioavailability in hairless rats of tretinoin in liposomes or gel
12. A quantitative method for measuring antipsoriatic activity of drugs by the mouse tail test
13. Psoriasis
14. Effect of crude coal tar in the mouse-tail model of psoriasis
15. Testing of lipoxygenase inhibitors, cyclooxygenase inhibitors, drugs with immunomodulating properties and some reference anti-psoriatic drugs in the modified mouse tail test, an animal model of psoriasis
16. Effect of fumaric acid, its dimethylester, and topical antipsoriatic drugs on epidermal differentiation in the mouse tail model
17. Tazarotenen induces epidermal cell differentiation in the mouse tail test used as an animal model for psoriasis
18. Effects of calcipotriol (MC 903) and calcitriol after topical application on the skin of hairless rats
19. 3-derivatives in liposomes of different lipid types
20. 3
21. Increase of lipid fluidity and suppression of proliferation resulting from liposome uptake by human keratinocytes in vitro
22. 3-analogues and human keratinocytes
23. 3 stimulates specifically the last steps of epidermal differentiation of cultured human keratinocytes
24. 3)
25. Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms
26. Topical delivery of liposomally encapsulated gamma-interferon